HROW | HarrowNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$28.54
+$0.34 (+1.21%)

Harrow (HROW) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.

The 50 SMA has sat below the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $28.54 vs 50 $32.38 / 200 $38.15
Projection
No cross projected
Test
No active test
Last cross
Death cross 28 Aug 2026 ยท projected 16 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $28.24 vs 50 $39.53 / 200 $28.61
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 16:00 ET

Price
below both $28.54 vs 50 $29.12 / 200 $36.85
Projection
No cross projected
Test
No active test
Last cross
Death cross 15 Sep 2026 ยท projected 27 bars out

Cross history

21
crosses on record since 2019
10 golden11 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
15 Sep 2026Death4-hour27 bars outNot tested
28 Aug 2026Death flatdaily16 bars outNot tested
21 Aug 2026Golden moderatedaily3 bars out3 bar cross test
7 Jul 2026Golden4-hour27 bars outNot tested
17 Apr 2026Death moderatedaily30 bars out6 bar cross test

About HROW

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$17.2M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.